Last Updated on April 27, 2026

You’ve probably heard some version of this phenomenon by now: people take Ozempic (or another GLP-1) and suddenly lose interest in alcohol. It gets framed as a kind of side-effect miracle—weight loss, fewer cravings, maybe even less desire to drink.

There’s truth in that. But there are also important nuances to consider.

Naltrexone and GLP-1 medications can both lead to drinking less. That doesn’t mean they’re interchangeable, or even solving the same problem in the same way. One was built for alcohol use disorder (AUD) and has decades of data behind it. The other wandered into the conversation through patient anecdotes that researchers are still trying to map out.

If you’re trying to figure out what’s actually useful—not just interesting—those differences matter more than the headline.

How Naltrexone Actually Changes Drinking Behavior

Alcohol has a way of teaching the brain what to expect, not in a conscious way or a way that’s connected to rationality, but through repetition. You drink, you feel something good, your brain logs that activity as something worth doing again.

Alcohol triggers endorphin release, which activates opioid receptors and, downstream, boosts dopamine. That layered response is a big reason drinking can feel reinforcing beyond just taste or habit.

Naltrexone steps into that loop and interrupts it.

It blocks those opioid receptors, so the usual cascade gets muted. The drink is still the drink, but the payoff is flatter. Not gone, exactly—just less convincing. Over time, that difference starts to add up. The brain adjusts its expectations, and the pull toward alcohol often softens with it.

In terms of logistics, it’s fairly simple. Most people take a daily pill, though there’s also a monthly injection. Side effects tend to be manageable—nausea comes up the most, especially early on, but it often fades as things level out.

What stands out is how specifically this medication maps to drinking behavior. It’s not a side benefit. It’s the point.

What’s Going On With GLP-1 Drugs and Alcohol Cravings?

GLP-1 drugs took a very different path into this conversation.

GLP-1 receptor agonists were originally developed to treat type 2 diabetes, with weight loss emerging as a secondary effect that later became its own use. The alcohol piece showed up later, almost incidentally. Patients would mention, sometimes offhand, that they just weren’t thinking about drinking as much.

That pattern showed up often enough that it stopped sounding like a coincidence.

From a biology standpoint, it’s plausible. GLP-1 receptors are active in parts of the brain tied to reward and motivation, not just appetite. When those receptors are stimulated, dopamine signaling appears to shift in a broader way. Food cravings go down. In some cases, other compulsive behaviors seem to quiet as well.

Alcohol fits into that category.

Still, a one-to-one comparison isn’t really possible when we’re thinking about naltrexone vs. GLP-1.  The mechanisms don’t line up cleanly. Naltrexone is more targeted—it blocks a specific piece of the alcohol reward pathway. GLP-1 drugs seem to work more diffusely, nudging the system rather than cutting off a single route.

The research reflects the difference in maturity. Observational studies are showing lower rates of alcohol-related diagnoses among people on GLP-1 medications. Smaller trials and preclinical studies point in the same direction. But large, definitive trials designed specifically around alcohol use disorder are still in progress.

So the signal is there. It’s just not fully resolved yet.

Then there’s the practical side. These medications are usually prescribed off-label if alcohol is the focus, which means insurance coverage is unlikely. Costs can climb quickly. Side effects—especially gastrointestinal ones—are also more noticeable for a lot of people, and alcohol can complicate things further, given how these drugs affect digestion and blood sugar.

Comparing Naltrexone vs. GLP-1 Medications

If you make a naltrexone vs. GLP-1 comparison, the contrast is less about outcome and more about certainty.

Naltrexone has been studied directly for alcohol use disorder for decades. It has FDA approval for that use, clear dosing strategies, and a fairly predictable profile in terms of what to expect.

By contrast, GLP-1 medications are still being understood in this context. The early data is compelling enough to take seriously, but it’s not settled.

They also approach the same general system from different angles. One blocks opioid receptors tied to alcohol’s reward. The other activates GLP-1 receptors that seem to influence dopamine signaling more broadly. You end up in a similar place—a reduced pull toward alcohol—but the routes aren’t interchangeable.

That difference shows up in how they’re used. Naltrexone has been built into both abstinence and moderation-based approaches, including ones where drinking continues during treatment. GLP-1 drugs don’t have that kind of structured framework for alcohol yet.

Naltrexone vs. GLP-1: Which One Makes Sense for You?

At a high level, the decision usually comes down to what you’re actually trying to change.

If the goal is specifically to drink less, naltrexone tends to be the more straightforward option. It was designed for that use, it’s accessible, and there’s a long track record behind it.

If you’re already on a GLP-1 medication and noticing that alcohol has lost some of its appeal, that’s worth paying attention to. It’s not just anecdotal at this point, even if the research is still catching up.

Cost can tip the scale pretty quickly. Naltrexone is often inexpensive. GLP-1 medications, used this way, usually aren’t.

Why Medication Usually Isn’t the Whole Story

Even when medication changes how alcohol feels, it doesn’t automatically change the patterns you have around drinking.

A lot of drinking is predicated on habit. End of the day, certain social settings, specific emotional states—those cues don’t disappear just because the reward is dialed down. They can keep running in the background at a quieter hum.

That’s why behavior tends to matter just as much as biology here. Tracking your drinking with a tool like Sunnyside can start to make those patterns visible. Over time, that awareness can help you make deliberate shifts in your routines, especially when the reward at stake is not feeling as great as it used to.

There’s also the physical side of things. Alcohol interacts with sleep, stress hormones, and mood in ways that can reinforce the cycle. If those pieces stay in place, it’s easier for the habit to hang on, even if it’s less rewarding than it used to be.

In practice, the change tends to stick when both layers move together. The medication alters the signal. Your behavior changes the response. One without the other can help, but the combination is usually where things start to feel different in a lasting way.

That combination of medication access and behavioral structure is what Sunnyside Med is built around: naltrexone prescribed with clinical oversight, alongside the tracking and support tools that help the medication do its job across the weeks and months when the real rewiring happens.

More about Sunnyside and Naltrexone

Sunnyside is a holistic program to help you build a healthier relationship with alcohol, using a proven, science-backed method. Whether you want to become a more mindful drinker, drink less, or eventually quit drinking, Sunnyside can help you reach your goals. We take a positive, friendly approach to habit change, so you never feel judged or pressured to quit.

When you join Sunnyside, you’ll start by completing a 3-minute private assessment so we can learn a bit about you. Once that’s done, you’ll get a 15-day free trial to test out everything, including our daily habit change tools, tracking and analytics, community and coaching, and education and resources. It’s a full package designed specifically to adapt to your goals and help you reach them gradually, so you can make a huge impact on your health and well-being.

In addition, Sunnyside Med now offers access to compounded naltrexone, a prescription medication that can reduce cravings and binge drinking, giving you the peace of mind to make long-term change.

Get your 15-day free trial of Sunnyside today, and start living your healthiest life.

References

Anton RF, et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study. JAMA, 295(17):2003-2017.

Volpicelli JR, et al. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49(11):876-880.

Hendershot CS, et al. (2024). Semaglutide and alcohol use disorder. JAMA Psychiatry. JAMA

Leggio L, et al. (2023). GLP-1 receptor agonists are promising but unproven treatments for AUD. Nature Medicine, 29:2993-2995.

NIAAA. Medications for Alcohol Use Disorder. Updated 2023. niaaa.nih.gov